Sandra Kiazyk, University of Manitoba

Research

Read how they describe their research on their University of Manitoba profile.

Latest papers

The Role of Type I Interferons in Tuberculosis and in Tuberculosis-Risk-Associated Comorbidities.
Infectious disease reports · 2025 · senior author
Type I interferons and Mycobacterium tuberculosis whole cell lysate induce distinct transcriptional responses in M. tuberculosis infection.
Tuberculosis (Edinburgh, Scotland) · 2023 · senior author
Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination.
Nature communications · 2022

All 8 publications

Latest funding

Defining variation in Tuberculosis and HIV specific cellular immune responses during latent and active TB infection
CIHR · 2013 · Co-investigator
$100,000

All 1 grants and awards

8 publications.

01

The Role of Type I Interferons in Tuberculosis and in Tuberculosis-Risk-Associated Comorbidities.

Mutua F, Su RC, Ball TB, Kiazyk S

Infectious disease reports20253 citationsSenior authorOpen Access

DOI: 10.3390/idr17040081 PMID: 40700327

02

Type I interferons and Mycobacterium tuberculosis whole cell lysate induce distinct transcriptional responses in M. tuberculosis infection.

Mutua F, Su RC, Mesa C, Lopez C, Ball TB, Kiazyk S

Tuberculosis (Edinburgh, Scotland)20233 citationsSenior authorOpen Access

DOI: 10.1016/j.tube.2023.102409 PMID: 37729851

03

Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination.

Ssemaganda A, Nguyen HM, Nuhu F, Jahan N, Card CM, Kiazyk S, Severini G, Keynan Y, Su RC, Ji H, Abrenica B, McLaren PJ, Ball TB, Bullard J, Van Caeseele P, Stein D, McKinnon LR

Nature communications202285 citationsOpen Access

DOI: 10.1038/s41467-022-30913-4 PMID: 35688805

04

Evaluation of a collaborative model for successful implementation of a National CD4 enumeration EQA program in Cameroon.

Sagnia B, Kiazyk S, Meyers AFA, Plews M, Diallo TO, Sosso SM, Ambada G, Kamgaing R, Nji N, Sandstrom P, Ball BT, Nchinda G, Ndjolo A

Scientific reports20211 citationsOpen Access

DOI: 10.1038/s41598-021-91015-7 PMID: 34078982

05

Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assay

Michael G. Becker, Tracy Taylor, Sandra A. Koesters Kiazyk, Dana R. Cabiles, Adrienne F. A. Meyers, Paul A. Sandstrom

PLoS ONE202038 citationsOpen Access

DOI: 10.1371/journal.pone.0241959 PMID: 33166373

06

Evaluation of host genetics on outcome of tuberculosis infection due to differences in killer immunoglobulin-like receptor gene frequencies and haplotypes.

Braun K, Wolfe J, Kiazyk S, Kaushal Sharma M

BMC genetics2015

DOI: 10.1186/s12863-015-0224-x PMID: 26077983

07

Cytokine and chemokine expression profiles in response to Mycobacterium tuberculosis stimulation are altered in HIV-infected compared to HIV-uninfected subjects with active tuberculosis.

Waruk JL, Machuki Z, Mesa C, Juno JA, Anzala O, Sharma M, Ball TB, Oyugi J, Kiazyk S

Tuberculosis (Edinburgh, Scotland)2015Senior author

DOI: 10.1016/j.tube.2015.05.001 PMID: 26073895

08

For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

Luo M, Daniuk CA, Diallo TO, Capina RE, Kimani J, Wachihi C, Kimani M, Bielawny T, Peterson T, Mendoza MG, Kiazyk S, Ball TB, Plummer FA

Journal of virology201227 citationsOpen Access

DOI: 10.1128/jvi.05721-11 PMID: 22072744

Defining variation in Tuberculosis and HIV specific cellular immune responses during latent and active TB infection

Co-investigatorCIHR2013Operating Grant - PA: Bridge Funding -CHVI Vaccine Discovery and Social Research

Principal investigators: Ball, Terry B

Keywords: Hiv; Hiv Vaccine; Reactivation; T Cell Immunity; Tb Diagnostics; Tuberculosis

$100,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Department of Medical Microbiology and Infectious Diseases
Department of Internal Medicine
Other

1 shared papers, latest 2012

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Kiazyk, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The Role of Type I Interferons in Tuberculosis and in Tuberculosis-Risk-Associated Comorbidities." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]